Market revenue in 2021 | USD 5.3 million |
Market revenue in 2030 | USD 9.1 million |
Growth rate | 6.3% (CAGR from 2021 to 2030) |
Largest segment | Quadrivalent |
Fastest growing segment | Quadrivalent |
Historical data | 2018 - 2020 |
Base year | 2021 |
Forecast period | 2022 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Bivalent, Quadrivalent |
Key market players worldwide | Pfizer Inc, Sanofi SA, GSK PLC, Merck & Co Inc, Serum Institute of India Pvt. Ltd., Walvax Biotechnology |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to meningococcal vaccines market will help companies and investors design strategic landscapes.
Quadrivalent was the largest segment with a revenue share of 81.13% in 2021. Horizon Databook has segmented the Colombia meningococcal vaccines market based on bivalent, quadrivalent covering the revenue growth of each sub-segment from 2018 to 2030.
Rise in per capita healthcare expenditure, high incidence & awareness about meningococcal disease, and better immunization programs in Colombia are anticipated to boost market growth. The incidence of IMD is around 0.21 cases per 100,000 population, and it has witnessed an upsurge in the last few years.
Serogroup B predominate the market, followed by serogroups Y and C. Columbia has robust immunization program. Current program provide 22 vaccines for 26 different diseases, covering almost 97% of children aged 1 and below. Quadrivalent meningococcal vaccine is included in the National Immunization Program in the country.
Hence, the vaccine uptake for Men ACWY has been increasing in the country. The government is focusing on financial coverage through its national health system, with the push to reach universal health coverage.
Horizon Databook provides a detailed overview of country-level data and insights on the Colombia meningococcal vaccines market , including forecasts for subscribers. This country databook contains high-level insights into Colombia meningococcal vaccines market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account